Health & Nutrition
Novo CEO tells CNBC why drugmaker is rebranding, needs...
The Danish drugmaker called the changes the beginning of a new chapter for the company,...
Novo Nordisk rebrands to 'Novo,' CEO tells CNBC drugmaker...
The Danish drugmaker called the changes the beginning of a new chapter for the company,...
Athletes with autism take center court at the US Open
Young athletes with autism were on the US Open courts with Love Serving Autism,...
Novo Nordisk rebrands to 'Novo,' unveils corporate changes...
The Danish drugmaker called the changes the beginning of a new chapter for the company,...
Here’s a rapid-fire update on our 33-stock portfolio, including...
Jim's current faves include three tech names and a bank stock.
The Many Conflicts of Interest Behind the Meat Studies
The same person paid by Big Sugar to downplay the risks of sugar was paid by Big...
A rare disease is taking his vision. A gene therapy could...
A well-connected family’s fight to access a potential treatment for their son highlights...
Jim Cramer says investors are too focused on AI stocks....
CNBC's Jim Cramer said investors should look beyond the AI data-center trade as...
Pharma major Novartis falls 10% after three drug trial...
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial...
'Patients pay the tariff': Swiss pharma CEO warns of Trump's...
Sandoz CEO Richard Saynor warns steep U.S. tariffs on imported generic drugs could...
